Public COA audit
Semaglutide
Audited July 28, 2026
Multiple signals on this document conflict with known lab formats or verification patterns.
- Legitimacy
- 15
- Confidence
- 92%
- Panels
- 4/7
- Purity (printed)
- 99.9%
Scored poorly because audit signals point to fabrication or reused paperwork, limited panel coverage (4/7), 2 critical findings, and notable note: "Future dates (2026)". To improve: replace this file with an original lab certificate that verifies on the lab portal and include identity, purity, and endotoxin at minimum.
Document details
Fields extracted from the certificate — not order or payment data.
- Batch / lot
- SEMA10-0616
- Identity method
- MALDI-MS
- Sample date
- 2026-06-19
- Issue date
- 2026-06-25
Original certificate
Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.
7-panel checklist
Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.
4 of 7 present · 4 passed · 0 failed · 0 reported · 3 missing
Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.
Identity
Tested · passed · core
Compound identity confirmed (e.g. HPLC, mass spec).
Semaglutide
Purity
Tested · passed · core
Reported purity percentage for the analyte.
99.9%
Heavy metals
Tested · passed
Lead, arsenic, cadmium, mercury, or similar limits.
<0.01 ppm
Microbial
Not on this certificate file
Bioburden / microbial limits testing.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
Endotoxin
Tested · passed · core
LAL or chromogenic endotoxin assay.
<0.05 EU/mL
Sterility
Not on this certificate file
Sterility testing where applicable.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
Residual solvent / water
Not on this certificate file
Residual solvents or water content limits.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
How to read this
Had data · good
Panel present with a pass (or clear acceptance).
Had data · bad
Panel present with a fail — a concrete quality signal.
Had data · unclear
Value reported without an explicit pass/fail mark.
Missing on this file
Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.
Findings
Evidence-linked observations from this audit.
Future dates (2026)
Sample received June 19, 2026 and COA issued June 25, 2026 — both dates are in the future, which is impossible for a legitimate document created in 2024 or earlier
Unverifiable testing laboratory
Bioviridian does not appear to be a known or established analytical testing laboratory for peptides. The URL bioviridians.com cannot be verified as a legitimate testing facility
Product image watermark mismatch
The HPLC chromatogram contains an 'American Peptides' logo/watermark, but the vendor is listed as 'American Peptides' and the testing lab is 'Bioviridian' — suggests possible mixing of vendor marketing materials with purported independent testing
Suspiciously perfect purity
99.9% purity is exceptionally high and at the upper limit of what is typically achievable; while possible, this combined with other red flags raises concern
Mass spectrum shows single peak
The mass spectrum shows molecular weight 4115.683 [M+H]+ which is close to expected semaglutide MW (4113.6 listed), but the extremely clean single peak with no impurities is unusual for a real sample
Batch number present
Lot number SEMA10-0616 is clearly stated
Missing microbial and sterility testing
No microbial contamination or sterility testing reported, which would typically be included for pharmaceutical-grade peptides
PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.